First Republic Investment Management Inc Makes New Investment in Exelixis, Inc (NASDAQ:EXEL) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
10,875 Shares in Exelixis, Inc (NASDAQ:EXEL) Purchased by C M Bidwell & Associates Ltd etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Mackenzie Financial Corp Sells 71,715 Shares of Exelixis, Inc (NASDAQ:EXEL) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Corporate priorities for 2022 include initial readout of up to three cabozantinib pivotal trials; initiation of pivotal trial program for XL092; expansion of clinical programs for XL092, XB002 and XL102; and multiple new development candidates from small molecule and biologics programs Cabozantinib franchise ac.